11 results
6-K
EX-99.1
LEGN
Legend Biotech Corp
14 Apr 23
Master Technology Transfer, Manufacturing and Clinical Supply Services Agreement for Bcma Car-t Product
8:30am
of this Agreement pertinent to their engagement, each applicable Work Order and each applicable Quality Agreement and (ii) for all actions … employees, agents and contractors, as applicable, fall outside the scope of their employment or engagement by the applicable Party. Provider shall
CORRESP
LEGN
Legend Biotech Corp
11 Oct 22
Correspondence with SEC
12:00am
control over financial reporting to be filed with the SEC, effective on June 1, 2022 and (ii) approved the engagement of Ernst & Young LLP, located … into an engagement letter with Ernst & Young LLP. However, there are no guarantees that engaging Ernst & Young LLP will remove us from being a “Commission-Identified
CORRESP
o5q26a
30 Sep 22
Correspondence with SEC
12:00am
6-K
EX-99.1
svrc f4hy
16 Sep 22
Current report (foreign)
4:00pm
6-K
hihjhfs0nr9hk
9 May 22
Legend Biotech Corporation 6-K
6:30am
S-8
EX-10.1
idcfqfx 5bu2ndr
26 Jun 20
Registration of securities for employees
4:11pm
F-1/A
EX-10.2
8y0n4raqxu3eoibz
29 May 20
Registration statement (foreign) (amended)
8:32am
F-1
EX-10.5
hlfl2
13 May 20
Registration statement (foreign)
4:41pm
- Prev
- 1
- Next